Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
639 studies found for:    "ulcerative colitis"
Show Display Options
Rank Status Study
21 Completed ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.
Condition: Ulcerative Colitis
Intervention: Drug: Alicaforsen
22 Completed
Has Results
A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
Condition: Ulcerative Colitis
Interventions: Drug: GWP42003;   Drug: Placebo
23 Completed A Double Blind Study for the Treatment of Acute Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Mesalamine
24 Unknown  Oral OKT3 for the Treatment of Active Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Oral OKT3
25 Completed Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA
Condition: Ulcerative Colitis
Intervention:
26 Enrolling by invitation Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Interventions: Drug: MTX 12.5;   Drug: MTX 25;   Drug: Adalimumab
27 Unknown  NBI With Magnification for Dysplasia Detection in Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Procedure: Narrow Band Imaging;   Procedure: colonoscopy
28 Terminated A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.
Condition: Ulcerative Colitis
Intervention: Drug: mesalamine
29 Completed Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission
Condition: Ulcerative Colitis
Intervention: Drug: Pentasa
30 Completed
Has Results
(CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Procedure: Blood sampling, endoscopy;   Drug: Budesonide MMX® 6 mg;   Drug: Budesonide MMX® 9 mg;   Drug: Entocort EC® 3 mg;   Drug: Placebo
31 Terminated A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: visilizumab
32 Unknown  Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Aloe Barbadensis Miller;   Dietary Supplement: placebo water
33 Completed
Has Results
(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Procedure: Blood sampling, endoscopy;   Drug: budesonide-MMX® 6 mg;   Drug: budesonide-MMX® 9 mg;   Drug: Placebo;   Drug: Asacol® 400 mg
34 Terminated A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Biological: fecal microbiota transplantation
35 Active, not recruiting Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Intervention: Biological: Fecal Microbiota Transplantation
36 Completed
Has Results
A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.
Condition: Ulcerative Colitis
Interventions: Drug: CP- 690 550;   Other: placebo
37 Terminated Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Behavioral: Observe patients with inactive ulcerative colitis
38 Recruiting Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Infliximab
39 Not yet recruiting Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: berberine;   Drug: regular treatment
40 Completed A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Device: Active TLA Gut™ column;   Device: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.